Title
IX BIOPHARMA: Gets approval for S'pore sale of erectile dysfunction drug
YANGZIJIANG: Cheap at 0.5x P/BV and 5x P/E ex-cash
WILMAR: Divergent price action between WIL & YKA unjustified
FOOD EMPIRE: "Current share price offers good entry point," says RHB
iX BIOPHARMA: Q&A on out-licensing, potential use of sublingual technology
DBS report: Malaysia Strategy & Stock Picks
DBS' 3Q results season picks: AEM, UMS, CAO, Thai Bev, CMT
JAPFA: 3Q core net profit forecast to grow 123%
Key beneficiaries of electric vehicle boom: Chinese EV battery material players
TOP GLOVE: 10 Questions & Answers

Page 9 of 44

 

We have 952 guests and one member online

rss_2 NextInsight - Latest News

All Rights Reserved @ NextInsight Pte Ltd